Co-expression network analysis of Down's syndrome based on microarray data.

Area of Science:

• Genetics
• Molecular Biology
• Bioinformatics

Background:

• Down syndrome (DS) is a genetic disorder caused by trisomy 21.
• Understanding the molecular mechanisms underlying DS is crucial for developing targeted therapies.

Purpose of the Study:

• To identify differentially expressed genes (DEGs) in Down syndrome.
• To explore molecular pathways and gene co-expression networks associated with DS pathogenesis.
• To evaluate the diagnostic potential of identified DEGs and modules.

Main Methods:

• Utilized gene expression omnibus (GEO) database (GSE5390) for microarray data analysis.
• Performed differential gene expression analysis, pathway enrichment, and co-expression network construction.
• Employed mutual information for module mining and leave-one-out cross-validation for classification accuracy assessment.

Main Results:

• Identified 997 DEGs (638 upregulated, 359 downregulated) in DS.
• Upregulated DEGs were enriched in cell adhesion molecules; downregulated DEGs in maturity onset diabetes of the young.
• Selected three significant differential modules; 12 DEGs within these modules showed high classification accuracy (72.73%) for DS samples.
• Significant enrichment of functions including endoplasmic reticulum and regulation of apoptosis.

Conclusions:

• Identified DEGs and significant differential modules, particularly 12 key genes, offer insights into DS molecular pathogenesis.
• These genes, including BCLAF1, HSP90AB1, UBXN2, and TMEM50B, may play critical roles in DS.
• The findings provide potential molecular targets for future Down syndrome research and therapeutic strategies.